2018 Tumor Marker Testing Market Competitive Landscape: Strategic Assessments of Leading Suppliers

This new 80-page report from Venture Planning Group provides insightful analyses of major current and emerging suppliers of tumor marker diagnostic instruments and reagents. 

The assessments include:

  • Sales
  • Product portfolios
  • Distribution tactics
  • Technological know-how
  • New products in R&D
  • Collaborative arrangements
  • Business strategies.

Abbott
- AdnaGen/Alere
- Agilent Technologies
- Applied Gene Technologies
- Arca Biopharma
- Beckman Coulter/Danaher
- Becton Dickinson
- Biomedical Diagnostics
- bioMerieux
- Bio-Rad
- CellSearch
- Cepheid
- Correlogic Systems/Vermillion
- Decode Genetics
- Diadexus
- Diagnocure
- Diasorin
- Eiken Chemical
- Elitech Group
- Epigenomics
- Enterix
- Enzo Biochem
- Exact Sciences
- Fujirebio
- Guided Therapeutics
- Hologic/Gen-Probe
- Kreatech/Leica
- Kyowa Medex
- Mackay Life Sciences
- Myriad Genetics
- OncoLab
- Ortho-Clinical Diagnostics
- Panacea Pharmaceuticals
- Polartechnics
- Polymedco
Table of Contents
- PreMD
- Qiagen
- Quest Diagnostics
- Radient Pharmaceuticals
- Roche
- Scienion
- Sequenom
- Siemens Healthcare
- Takara Bio
- Targeted Diagnostics & Therapeutics
- Thermo Fisher
- Tosoh
- Veridex
- Wako Pure Chemicals
- Wallac/PE
- Zila/Alere


2018 Healthcare Research Review

Report Scope:The scope of this report is broad. It covers components, applications, end users and modes of deployment in 3D medical and surgical platforms. The market has been segmented by

USD 950 View Report

2019 Tumor Markers Testing Instrumentation: Cancer Diagnostic Analyzers and Strategic Profiles of Leading Suppliers

This 119-page report reviews current instrumentation technologies, and compares features of major automated and semiautomated analyzers used for cancer diagnostic testing. The report also presents strategic assessments of current and

USD 3850 View Report

2019-2023 CA Tumor Markers Testing Market: US, Europe, Japan--Emerging Opportunities, Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Technologies and Opportunities

The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery

USD 5450 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available